title: Stroke in sickle cell anemia patients: a need for multidisciplinary approaches.
abstract: Sickle cell anemia (SCA) is an autosomal recessive disorder, with Mendelian inheritance pattern, caused by a missense mutation in the β-polypeptide chain of the hemoglobin B. SCA preferentially affects populations in countries where malaria was/is present (e.g. Africa, USA, Brazil). Thereby, in USA, the incidence of SCA is relatively high, around 1/500, and the prevalence is about 1/1000. In Brazil, SCA represents a major public health problem with an incidence ranging from 1/2000 to 1/600 depending on the regions. Homozygotic patients present more severe medical conditions and reduced life expectancy than heterozygous individuals who generally are asymptomatic. Eventually, this life-threatening disease displays a complex etiology owing to heterogeneous phenotypes and clinical outcomes, subsequently affecting the management of the patients. One of the most critical complications associated with SCA is stroke, a leading neurologic cause of death and disability. About 24% of SCA patients have a stroke by the age of 45 and 11% by the age of 20. From the general population, twin and familial aggregation studies as well as genome-wide association studies (GWAS), mostly in pediatric populations with ischemic stroke, showed that the risk of stroke has a substantial genetic component. Nevertheless, to fully characterize genomic contributors of stroke and permit reliable personalized medicine, multidisciplinary studies incorporating knowledge from clinical medicine, epidemiology, genetics, and molecular biology, are required. In this manuscript, stroke in SCA patients is extensively reviewed with emphasis to the US and Brazilian populations. Recent advances in genomics analysis of stroke in SCA patients are highlighted.
authors.affiliation: Center of Hematology and Hemotherapy (Hemocentro), School of Medicine and Medical Sciences (FCM), University of Campinas (UNICAMP), São Paulo, Brazil. dr.fmenaa@gmail.com
authors.forename: Farid
authors.initials: F
authors.lastname: Menaa
mesh_terms: D000755:Anemia, Sickle Cell / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D055106:Genome-Wide Association Study; D006454:Hemoglobins / Q000235:genetics*; D006801:Humans; D015994:Incidence; D033183:Interdisciplinary Communication; D015995:Prevalence; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology / Q000235:genetics / Q000628:therapy
chemical_list: D006454:Hemoglobins; C020622:hemoglobin B
keywords: Copy-number variations; Genome-wide association studies; Personalized and translational medicine; Sickle cell anemia; Single nucleotide polymorphisms; Stroke